Menveo
NDC 58160-955, Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, kit, from GlaxoSmithKline Biologicals SA.
- Product NDC
- 58160-955
- Status
- Listed
- Labeler
- GlaxoSmithKline Biologicals SA
- Dosage form
- KIT
- Route
- —
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125300
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58160-955 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58160-955-09 | 58160095509 | 1 KIT in 1 CARTON (58160-955-09) * .5 mL in 1 VIAL, SINGLE-DOSE (58160-958-01) * .5 mL in 1 VIAL, SINGLE-DOSE (58160-959-01) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58160-955 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58160-955 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58160-955. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.